Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its access is overseen by Health Canada. https://lisdexamfetaminepriceinc476945.blog-tecnologia.com/61745419/vyvanse-in-canada-a-detailed-guide